• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene.

作者信息

Ymer S, Tucker W Q, Sanderson C J, Hapel A J, Campbell H D, Young I G

出版信息

Nature. 1985;317(6034):255-8. doi: 10.1038/317255a0.

DOI:10.1038/317255a0
PMID:2413359
Abstract

Interleukin-3 (multi-CSF) is a multilineage haematopoietic growth regulator that initiates the proliferation and differentiation of multipotential stem cells. Complementary DNA clones encoding interleukin-3 (IL-3) have recently been isolated and the structure of the IL-3 gene determined. IL-3 is produced by T lymphocytes or T lymphomas only after stimulation with antigens, mitogens or chemical activators such as phorbol esters. The myelomonocytic leukaemia line WEHI-3B also produces IL-3 but its production is constitutive and the WEHI-3B cells do not appear to produce significant levels of any of the other lymphokines normally secreted by T lymphocytes after stimulation. It has been proposed that the genetic change leading to the constitutive expression of IL-3 may have been a key event in the development of this leukaemia. We report here that the constitutive synthesis of IL-3 by the WEHI-3B cell line is due to the insertion of an endogenous retrovirus-like element close to the 5' end of the gene. The insertion, an intracisternal A particle (IAP) genome, is positioned with its 5' long terminal repeat (LTR) close to the promoter region of the IL-3 gene, resulting in constitutive synthesis of IL-3.

摘要

相似文献

1
Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene.
Nature. 1985;317(6034):255-8. doi: 10.1038/317255a0.
2
Nucleotide sequence of the intracisternal A-particle genome inserted 5' to the interleukin-3 gene of the leukemia cell line WEHI-3B.插入白血病细胞系WEHI-3B白细胞介素-3基因5'端的脑内A颗粒基因组的核苷酸序列。
Nucleic Acids Res. 1986 Jul 25;14(14):5901-18. doi: 10.1093/nar/14.14.5901.
3
Abnormal expression of interleukin-3 and leukaemia.
Anticancer Res. 1987 Jul-Aug;7(4A):661-7.
4
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion.细胞原癌基因myc已通过逆转录病毒插入而被激活的小鼠T淋巴瘤。
Cell. 1984 May;37(1):113-22. doi: 10.1016/0092-8674(84)90306-4.
5
Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.WEHI-3细胞系组成性产生一种独特的淋巴因子(IL-3)。
J Immunol. 1982 Jun;128(6):2393-8.
6
Activation of mts1 transcription by insertion of a retrovirus-like IAP element.通过插入类逆转录病毒IAP元件激活mts1转录。
Gene. 1996 Feb 12;168(2):151-5. doi: 10.1016/0378-1119(95)00742-3.
7
Molecular cloning of retrovirus-like genes present in multiple copies in the Syrian hamster genome.叙利亚仓鼠基因组中多拷贝存在的类逆转录病毒基因的分子克隆。
Nucleic Acids Res. 1982 Oct 11;10(19):5733-46. doi: 10.1093/nar/10.19.5733.
8
Cloning and nucleotide sequence of the murine interleukin-3 gene.小鼠白细胞介素-3基因的克隆与核苷酸序列
Eur J Biochem. 1985 Jul 15;150(2):297-304. doi: 10.1111/j.1432-1033.1985.tb09020.x.
9
Studies on the in vivo production of a lymphokine activity, interleukin 3 (IL-3) elaborated by lymphocytes and a myeloid leukaemic line in vitro and the fate of IL-3 dependent cell lines.关于淋巴细胞和髓系白血病细胞系在体外产生的一种淋巴因子活性——白细胞介素3(IL-3)的体内生成情况以及IL-3依赖细胞系命运的研究。
Br J Cancer. 1983 Aug;48(2):247-59. doi: 10.1038/bjc.1983.180.
10
Generation of an autocrine leukaemia using a retroviral expression vector carrying the interleukin-3 gene.使用携带白细胞介素-3基因的逆转录病毒表达载体产生自分泌性白血病。
Lymphokine Res. 1986 Fall;5(4):249-54.

引用本文的文献

1
Identification of Candidate Signature Genes and Key Regulators Associated With Trypanotolerance in the Sheko Breed.识别与谢科品种抗锥虫能力相关的候选特征基因和关键调控因子。
Front Genet. 2019 Nov 14;10:1095. doi: 10.3389/fgene.2019.01095. eCollection 2019.
2
A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk mutation in B-cell malignancies.一种非共价抑制剂 XMU-MP-3 克服了 B 细胞恶性肿瘤中伊布替尼耐药的 Btk 突变。
Br J Pharmacol. 2019 Dec;176(23):4491-4509. doi: 10.1111/bph.14809. Epub 2019 Dec 9.
3
Role of Granulocyte-Macrophage Colony-Stimulating Factor in Acute Myeloid Leukemia/Myelodysplastic Syndromes.
粒细胞-巨噬细胞集落刺激因子在急性髓系白血病/骨髓增生异常综合征中的作用
J Glob Oncol. 2018 Sep;4:1-6. doi: 10.1200/JGO.2017.009332. Epub 2017 Sep 29.
4
IL-4 enhances survival of in vitro-differentiated mouse basophils through transcription-independent signaling downstream of PI3K.IL-4 通过 PI3K 下游非转录信号增强体外分化的小鼠嗜碱性粒细胞的存活。
Cell Death Dis. 2018 Jun 18;9(7):713. doi: 10.1038/s41419-018-0754-z.
5
BH3 mimetics efficiently induce apoptosis in mouse basophils and mast cells.BH3 模拟物能有效地诱导小鼠嗜碱性粒细胞和肥大细胞凋亡。
Cell Death Differ. 2018 Jan;25(1):204-216. doi: 10.1038/cdd.2017.154. Epub 2017 Sep 29.
6
ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro.白细胞介素-3、6和11可增强,但白细胞介素-10和24会降低人前列腺癌细胞在体外的干性。
Oncotarget. 2015 Dec 15;6(40):42687-703. doi: 10.18632/oncotarget.5883.
7
The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells.HuR在T细胞中白介素-3转录后调控中的作用。
PLoS One. 2014 Mar 21;9(3):e92457. doi: 10.1371/journal.pone.0092457. eCollection 2014.
8
Microarray-based global mapping of integration sites for the retrotransposon, intracisternal A-particle, in the mouse genome.基于微阵列技术对小鼠基因组中逆转录转座子——脑内A颗粒(intracisternal A-particle)整合位点的全基因组图谱绘制。
Nucleic Acids Res. 2008 Jun;36(10):e59. doi: 10.1093/nar/gkn235. Epub 2008 May 1.
9
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance.一种非ATP竞争性的BCR-ABL抑制剂可克服伊马替尼耐药性。
Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1992-7. doi: 10.1073/pnas.0408283102. Epub 2005 Jan 27.
10
Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c-Myb.与c-Myb的两种可变剪接产物调控细胞凋亡相关的分子机制。
Mol Cell Biol. 2003 Sep;23(18):6631-45. doi: 10.1128/MCB.23.18.6631-6645.2003.